Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 461-470 Newer>

The Motley Fool December 31, 2003 Bill Mann	To Do in 2004: Join the Crowd In 2003 we saw a year when speculative excesses came back with a vengeance. Like restaurants mocking health-code regulations, investors seemed to act according to a mantra of "no earnings, no prospects, no problem."
The Motley Fool December 31, 2003 W.D. Crotty	Abandon the Gold Standard? The major mining stocks are richly valued. Is there still money in gold?
InternetNews December 30, 2003 Erin Joyce	Micromuse Down, Symbol up on Accounting Probes The Nasdaq index stayed in above-2000 territory Tuesday on a subdued day of trading as the end-of-year New Year's holiday approached.
The Motley Fool December 30, 2003 Jeff Hwang	Trinity Scores With HIV Test FDA approval of 10-minute HIV test sends Trinity shares soaring.
The Motley Fool December 30, 2003 Dave Marino-Nachison	Not Feeling Quite Cosi Not all is bleak for the downbeat cafe company, though management's job is considerable.
The Motley Fool December 30, 2003 David Forrest	Dodging the Overpriced Bullet How to spot overvalued stocks by looking at the company's potential value when it has matured. With this method, Amazon.com seems very overpriced.
The Motley Fool December 30, 2003 Dave Marino-Nachison	United Online's Holding Pattern Is the near-term threat to this growing value ISP being overstated by investors?
The Motley Fool December 30, 2003 Don Crotty	Red-Hot ChromaVision Tiny diagnostics company takes flight on FDA approval.
The Motley Fool December 30, 2003 Tom Taulli	M&A As Strong Medicine Invitrogen's latest deal shows that the company knows where its market is headed.
The Motley Fool December 30, 2003 Rick Aristotle Munarriz	Wow! It's Nasdaq 2,000! Please pardon a yawn as an index celebrates a milestone.
<Older 461-470 Newer> Return to current articles.